The prevalence of dual diagnoses in children and adolescents with substance use disorders, systematic review

被引:1
作者
Jandac, Tomas [1 ,2 ]
Stastna, Lenka
机构
[1] Charles Univ Prague, Fac Med 1, Klin Adiktol 1 LF UK VFN Praze,Apolinarska 4, Prague 12800 2, Czech Republic
[2] Charles Univ Prague, Gen Univ Hosp Prague, Dept Addictol, Klin Adiktol 1 LF UK VFN Praze,Apolinarska 4, Prague 12800 2, Czech Republic
关键词
Substance use disorders; dual diagnosis; children; adolescents; ABUSE; COMORBIDITY;
D O I
10.1080/14659891.2023.2173089
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
BackgroundThe objective of this paper is to present a systematic review of studies dealing with the prevalence of dual diagnoses among children and adolescents with substance use disorders. The main objective of the study is to describe prevalence of dual diagnoses and to identify the relevant topics.MethodsThe Preferred Reporting Items for Systematic Reviews protocol and guidelines were used to conduct the systematic review. The EBSCO, Medline, Scopus, and Web of Science databases were searched for relevant articles published in English between 2010 and 2020.ResultsThe areas of interest were identified as (a) prevalence of dual diagnoses among substance-using children and adolescents, (b) methods for diagnosing psychiatric conditions, (c) psychiatric comorbidity diagnoses, (d) types of substances used, (e) differences between outpatient and inpatient participants. Literature on dual diagnoses in children and adolescents is scarce. The mean prevalence of dual diagnoses in target population with substance use disorders was 59.6%. As the most common psychiatric disorders, the studies indicate conduct disorders, anxiety and depressive disorders. We suggest that further research with study designs included valid diagnostic tools.ConclusionThe care of the target group should be provided with the respect of high prevalence of dual diagnoses.
引用
收藏
页码:393 / 398
页数:6
相关论文
共 18 条
[1]   Disparities in Treatment for Substance Use Disorders and Co-Occurring Disorders for Ethnic/Racial Minority Youth [J].
Alegria, Margarita ;
Carson, Nicholas J. ;
Goncalves, Marta ;
Keefe, Kristen .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2011, 50 (01) :22-31
[2]  
Babor T.F., 2017, Publishing Addiction Science: A Guide for the Perplexed
[3]  
Belcher HME, 1998, ARCH PEDIAT ADOL MED, V152, P952
[4]   Comorbid psychopathology in adolescents and young adults treated for substance use disorders [J].
Couwenbergh, Christianne ;
van den Brink, Wim ;
Zwart, Kirsten ;
Vreugdenhil, Coby ;
van Wijngaarden-Cremers, Patricia ;
van der Gaag, Rutger J. .
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2006, 15 (06) :319-328
[5]  
EMCDDA, 2004, DRUGS FOCUS, P14
[6]   Comorbidity of substance use disorders among community-based and high-risk adolescents [J].
Essau, Cecilia A. .
PSYCHIATRY RESEARCH, 2011, 185 (1-2) :176-184
[7]   The Comorbidity of Psychiatric and Substance Use Disorders Among Hispanic Adolescents [J].
Gattamorta, Karina A. ;
Mena, Maite P. ;
Ainsley, Jordan B. ;
Santisteban, Daniel A. .
JOURNAL OF DUAL DIAGNOSIS, 2017, 13 (04) :254-263
[8]   Predictors of First-Onset Substance Use Disorders During the Prospective Course of Bipolar Spectrum Disorders in Adolescents [J].
Goldstein, Benjamin I. ;
Strober, Michael ;
Axelson, David ;
Goldstein, Tina R. ;
Gill, Mary Kay ;
Hower, Heather ;
Dickstein, Daniel ;
Hunt, Jeffrey ;
Yen, Shirley ;
Kim, Eunice ;
Ha, Wonho ;
Liao, Fangzi ;
Fan, Jieyu ;
Iyengar, Satish ;
Ryan, Neal D. ;
Keller, Martin B. ;
Birmaher, Boris .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2013, 52 (10) :1026-1037
[9]  
James P. D., 2013, MENTAL HLTH SUBSTANC, V6, P124, DOI [10.1080/17523281.2012.693519, DOI 10.1080/17523281.2012.693519]
[10]   Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders [J].
Langenbach T. ;
Spönlein A. ;
Overfeld E. ;
Wiltfang G. ;
Quecke N. ;
Scherbaum N. ;
Melchers P. ;
Hebebrand J. .
Child and Adolescent Psychiatry and Mental Health, 4 (1)